1. Home
  2. CKX vs LEXX Comparison

CKX vs LEXX Comparison

Compare CKX & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

HOLD

Current Price

$11.13

Market Cap

18.8M

Sector

Energy

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.77

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
LEXX
Founded
1930
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
18.9M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CKX
LEXX
Price
$11.13
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
7.6K
307.9K
Earning Date
02-22-2026
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
2.14
N/A
EPS
0.23
N/A
Revenue
$897,333.00
$522,000.00
Revenue This Year
N/A
$13.35
Revenue Next Year
N/A
$78.83
P/E Ratio
$48.82
N/A
Revenue Growth
N/A
5.05
52 Week Low
$8.66
$0.46
52 Week High
$13.25
$1.91

Technical Indicators

Market Signals
Indicator
CKX
LEXX
Relative Strength Index (RSI) 75.55 47.56
Support Level $8.98 $0.68
Resistance Level $10.81 $0.86
Average True Range (ATR) 0.25 0.07
MACD 0.27 0.02
Stochastic Oscillator 100.00 50.80

Price Performance

Historical Comparison
CKX
LEXX

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: